Phase II study of gemcitabine and S-1 combination therapy in advanced pancreatic cancer with malignant ascites.
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2013
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Malignant ascites; Pancreatic cancer
- Focus Therapeutic Use
- 01 Oct 2013 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 20 Jul 2012 New trial record